Browsing Tag
FDA biosimilar guidelines
1 post
FDA accepts first biosimilar without clinical efficacy studies: Will this redefine global biologics access?
FDA waives efficacy trials for Stelara biosimilar, opening new doors for fast-track biosimilar access. Find out how this could reshape drug affordability worldwide.